Home › Asset managers › Compare 2024-2025 › Charles Schwab vs John Hancock
Charles Schwab 2024-2025 · John Hancock 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,674 | 7,532 | 466 | 676 | 94.2% | 91.7% |
| Board proposals | 7,415 | 6,620 | 379 | 416 | 94.6% | 92.9% |
| E&S shareholder proposals | 252 | 126 | 13 | 113 | 90.6% | 81.3% |
| Other items | 1,007 | 786 | 74 | 147 | 91.4% | 85.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
795 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | John Hancock |
|---|---|---|---|---|---|---|
| 8X8 INC. | August 15, 2024 | To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| ABEONA THERAPEUTICS INC. | December 20, 2024 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 3,200,000 to 8,400,000 shares. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ACELYRIN INC. | May 13, 2025 | To adopt the Agreement and Plan of Merger, dated February 6, 2025, among Alumis Inc., Arrow Merger Sub, Inc. and ACELYRIN, Inc., as may be amended from time to time. We refer to this proposal as the "ACELYRIN merger proposal." Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| ACLARIS THERAPEUTICS INC. | June 5, 2025 | To approve the Aclaris Therapeutics, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ACLARIS THERAPEUTICS INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 10, 2025 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders; Chad Robins Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 3 funds |
| ADC THERAPEUTICS SA | June 3, 2025 | The Board of Directors proposes that Jean-Pierre Bizzari be reelected as a director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2026 annual general meeting of Shareholders. Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ADT INC. | May 21, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 6 funds |
| ADVANCED FLOWER CAPITAL INC. | May 19, 2025 | Election of Director: Robert Levy Director Elections |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ADVANTAGE SOLUTIONS INC. | May 28, 2025 | To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| ADVERUM BIOTECHNOLOGIES INC. | June 17, 2025 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share as described in the Proxy Statement (as supplemented). Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| AEROVATE THERAPEUTICS INC. | April 16, 2025 | ESPP Proposal - To approve the Jade Biosciences, Inc. 2025 Employee Stock Purchase Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AEROVATE THERAPEUTICS INC. | April 16, 2025 | Redomestication Proposal - To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AERSALE CORP. | June 5, 2025 | To approve the Second Amendment to the AerSale Corporation 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| AEVA TECHNOLOGIES INC. | June 20, 2025 | Approval, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| AGENUS INC. | June 17, 2025 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AGENUS INC. | June 17, 2025 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AIR TRANSPORT SERVICES GROUP INC. | February 10, 2025 | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"). Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| ALBERTSONS COMPANIES INC. | August 8, 2024 | Election of Director: Sharon Allen Director Elections |
Board | For | FOR 13 funds |
AGAINST 3 funds |
| ALICO INC. | February 28, 2025 | Approval of the amendment and restatement of the Alico, Inc. Stock Incentive Plan of 2015. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| ALIGOS THERAPEUTICS INC. | June 25, 2025 | The amendment of our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of voting common stock from 20,000,000 shares to 100,000,000 shares; and Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ALPHATEC HOLDINGS INC. | June 11, 2025 | Approval of an amendment to our 2016 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| ALPINE INCOME PROPERTY TRUST INC. | May 21, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| ALX ONCOLOGY HOLDINGS INC | June 11, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| AMC NETWORKS INC | June 5, 2025 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| AMERICAN WELL CORP (AMWELL) | June 11, 2025 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company's proxy statement. Say-on-Pay |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| AMN HEALTHCARE SERVICES INC. | May 2, 2025 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| AMPHENOL CORP. | May 15, 2025 | Approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock Capital Structure |
Board | For | AGAINST 14 funds |
FOR 9 funds |
| AMTECH SYSTEMS INC. | March 5, 2025 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement; and Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ANAVEX LIFE SCIENCES CORP. | June 10, 2025 | To approve an amendment to the Company's 2022 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| ANTERIX INC. | August 6, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| ANYWHERE REAL ESTATE INC. | May 7, 2025 | Approval of the Third Amended and Restated 2018 Long-Term Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| API GROUP | May 16, 2025 | To approve the amendment of our certificate of incorporation to increase the number of authorized shares of common stock. Capital Structure |
Board | Not determined | AGAINST 12 funds |
FOR 5 funds |
| APPLIED DIGITAL CORP. | November 20, 2024 | Approve an amendment to the Company's Second Amended and Restated Articles of Incorporation, as amended, to increase the number of shares of common stock and the number of shares of preferred stock authorized for issuance thereunder. Capital Structure |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| APPLIED DIGITAL CORP. | November 20, 2024 | Approve the Company's 2024 Equity Compensation Plan and the reservation of 10,000,000 shares of common stock for issuance thereunder. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| APPLIED THERAPEUTICS INC. | June 9, 2025 | Election of Director: Teena Lerner Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AQUESTIVE THERAPEUTICS INC. | June 11, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| ARCELLX INC. | May 28, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025. Audit-related |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| ARDAGH METAL PACKAGING S.A. | May 27, 2025 | Elect Stefan Schellinger, as a Class II Director until the 2026 annual general meeting of shareholders. Director Elections |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| ARDELYX INC. | June 18, 2025 | To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| ARM HOLDINGS PLC | September 11, 2024 | To approve the rules of the Arm Holdings plc Employee Stock Purchase Plan 2024 (the "ESPP"), the principal features of which are summarised in the Appendix to this Notice of Annual General Meeting and that the directors of the Company be authorised to take such actions as may be necessary to facilitate the implementation of the ESPP. Compensation |
Board | None | AGAINST 2 funds |
FOR 2 funds |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| AST SPACEMOBILE INC. | June 6, 2025 | To approve a non-binding advisory vote on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval, by non-binding advisory vote, of our executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| ATLANTICUS HOLDINGS CORP. | May 8, 2025 | To approve the "say-on-pay" resolution set forth below: RESOLVED, that the shareholders of Atlanticus Holdings Corporation hereby approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the company's Proxy Statement for the 2025 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Summary Compensation Table and the other related tables and disclosure. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 6 funds |
| ATOMERA INC. | May 15, 2025 | To approve Amendment No.1 to the Company's 2023 Stock Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ATOMERA INC. | May 15, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| AVIAT NETWORKS INC. | November 6, 2024 | Approval of the Second Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| AVID BIOSERVICES INC. | January 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contentemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| AVITA MEDICAL INC. | June 4, 2025 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. Compensation |
Board | For | FOR 1 fund |
AGAINST 3 funds |
| AVITA MEDICAL INC. | June 4, 2025 | To approve the grant of 520,000 options to acquire shares of Common Stock to the Company's Chief Executive Officer, James Corbett, on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11. Compensation |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Adriane Brown Director Elections |
Board | For | AGAINST 13 funds |
FOR 10 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Graham Smith Director Elections |
Board | For | AGAINST 13 funds |
FOR 10 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Hadi Partovi Director Elections |
Board | For | AGAINST 13 funds |
FOR 10 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Michael Garnreiter Director Elections |
Board | For | AGAINST 13 funds |
FOR 10 funds |
| BAKKT HOLDINGS INC. | June 17, 2025 | To approve an amendment of the Company's Certificate of Incorporation to increase the number of authorized shares of Class A Common Stock. Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BANDWIDTH INC. | May 29, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| BANNER CORP. | May 22, 2025 | Approval of the adoption of the Banner Corporation 2025 Employee Stock Purchase Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| BBB FOODS INC. | April 29, 2025 | To re-elect Stephanie Martinez as a Class I Director of the Company, to hold office for a further term of three years (until the conclusion of the Company's annual meeting of shareholders in 2028). Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BEAM GLOBAL | September 23, 2024 | Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| BERRY GLOB | February 25, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the "Berry Advisory Compensation Proposal." Say-on-Pay |
Board | Not determined | FOR 14 funds |
AGAINST 7 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment to the 2005 Plan to increase the individual award limits for purposes of the issuance of the awards granted to Marcus A. Lemonis, the Company's Executive Chairman that exceed such limits (the "Contingent Awards"). Compensation |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2025 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| BIRKENSTOCK HOLDING PLC | April 29, 2025 | To re-appoint Nisha Kumar as a Class II director of the Company. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BLACKROCK FINANCE INC. | May 15, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 10 funds |
| BLOCK INC. | June 17, 2025 | TO APPROVE THE BLOCK, INC. 2025 EQUITY INCENTIVE PLAN. Compensation |
Board | For | FOR 13 funds |
AGAINST 2 funds |
| BLUE RIDGE BANKSHARES INC. | May 21, 2025 | To approve, in an advisory (non-binding) vote, the Company's named executive officer compensation disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| BLUEBIRD BIO INC. | December 4, 2024 | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| BORR DRILLING LIMITED | May 21, 2025 | To re-elect Neil J. Glass as a Director of the Company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| BOX INC. | July 2, 2024 | To approve our Amended and Restated 2015 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| BRANDYWINE REALTY TRUST | May 21, 2025 | Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 5 funds |
| BRUKER CORP. | May 29, 2025 | Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 4 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Christopher Halmy as director. Director Elections |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Robert Gillespie as director. Director Elections |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| BUTTERFLY NETWORK INC. | June 12, 2025 | To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| C.H. ROBINSON WORLDWIDE INC. | May 8, 2025 | To approve the Amended and Restated 2022 Equity Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 6 funds |
| C4 THERAPEUTICS INC. | June 18, 2025 | To approve an amendment to our Fifth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000. Capital Structure |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| CADIZ INC. | June 12, 2025 | Advisory vote on executive compensation as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| CAPITAL BANCORP INC | May 15, 2025 | Proposal to approve the Capital Bancorp, Inc. 2017 Stock and Incentive Compensation Plan, as amended and restated, to increase the number of shares of common stock authorized for issuance under the plan by 520,000 shares, from 2,020,000 shares to 2,540,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| CARDLYTICS INC. | May 20, 2025 | Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CAREDX INC. | June 12, 2025 | Approval of an amendment to 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CASSAVA SCIENCES INC. | May 23, 2025 | To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| CELCUITY INC. | May 13, 2025 | To approve, by a non-binding and advisory vote, compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| CENTURY ALUMINUM CO. | June 16, 2025 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| CERUS CORP. | June 3, 2025 | Equity Plan Proposals: The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. Compensation |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CEVA INC. | May 5, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CEVA INC. | May 5, 2025 | To approve an amendment and restatement of the Company's 2011 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CHATHAM LODGING TRUST | May 6, 2025 | Approval of an amendment to the Equity Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| CHEFS' WAREHOUSE INC. | May 9, 2025 | To approve an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| CHEGG INC. | June 4, 2025 | To approve the Chegg, Inc. Amendment to the 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| CHERRY HILL MORTGAGE INVESTMENT CORP. | June 12, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers for the year end December 31, 2024. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CIBUS INC | May 22, 2025 | Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CIBUS INC | May 22, 2025 | To approve the adoption of the Cibus, Inc. 2025 Employee Stock Purchase Plan. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CITI TRENDS INC. | June 5, 2025 | Vote to approve an Amendment to the 2021 Incentive Plan to increase the number of shares available by 500,000 for grant. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| CLARITEV CORP. | April 30, 2025 | Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
Page 1 of 8 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.